Filtered By:
Specialty: Pathology
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 1464 results found since Jan 2013.
Comparison of Clinical and Molecular Features Between Patients With Essential Thrombocythemia and Early/Prefibrotic Primary Myelofibrosis Presenting With Thrombocytosis in Taiwan
CONCLUSIONS: ET and pre-PMF-T were two distinct disease entities and exhibited different clinical phenotype, genotype, and outcomes.PMID:36857745 | DOI:10.1093/ajcp/aqac173
Source: American Journal of Clinical Pathology - March 1, 2023 Category: Pathology Authors: Ming-Chung Kuo Wen-Yu Chuang Hung Chang Tung-Huei Lin Jin-Hou Wu Tung-Liang Lin Che-Wei Ou Yu-Shin Hung Ting-Yu Huang Ying-Jung Huang Po-Nan Wang Lee-Yung Shih Source Type: research
Artificial Sweetener in Keto-Related Foods Tied to CV Risk Artificial Sweetener in Keto-Related Foods Tied to CV Risk
We need safety studies of long-term effects of artificial sweeteners in general, and erythritol specifically, on risks for heart attack and stroke, particularly in high-risk patients, says researcher.Medscape Medical News
Source: Medscape Pathology Headlines - February 28, 2023 Category: Pathology Tags: Cardiology News Source Type: news
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke
AbstractIschemic stroke (IS) is the leading cause of acquired disability and the second leading cause of dementia and mortality. Current treatments for IS are primarily focused on revascularization of the occluded artery. However, only 10% of patients are eligible for revascularization and 50% of revascularized patients remain disabled at 3 months. Accumulating evidence highlight the prognostic significance of the neuro- and thrombo-inflammatory response after IS. However, several randomized trials of promising immunosuppressive or immunomodulatory drugs failed to show positive results. Insufficient understanding of inter-...
Source: Seminars in Immunopathology - February 14, 2023 Category: Pathology Source Type: research
Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2 Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2
A new international trial has shown large benefits of thrombectomy in patients with ischemic strokes with a large core volume, which should lead to a change in clinical practice.Medscape Medical News
Source: Medscape Pathology Headlines - February 10, 2023 Category: Pathology Tags: Cardiology News Source Type: news
A review on the role of ADAMTS9-AS2 in different disorders
Pathol Res Pract. 2023 Jan 27;243:154346. doi: 10.1016/j.prp.2023.154346. Online ahead of print.ABSTRACTRecent decade has seen a tremendous progress in identification of the role of different long non-coding RNAs (lncRNAs) in human pathologies. ADAMTS9-AS2 is an example of lncRNAs with different roles in human disorders. It is mostly acknowledged as a tumor suppressor lncRNA in different types of cancers. However, it has been reported to be up-regulated in tongue squamous cell carcinoma, salivary adenoid cystic carcinoma and glioblastoma. Moreover, ADAMTS9-AS2 is possibly involved in the pathoetiology of pulpitis, acute is...
Source: Pathology, Research and Practice - February 6, 2023 Category: Pathology Authors: Soudeh Ghafouri-Fard Arian Askari Bashdar Mahmud Hussen Aria Baniahmad Mohammad Taheri Majid Mokhtari Source Type: research
Effectiveness of alteplase intravenous thrombolysis combined with butylphthalide in patients with acute severe cerebral infarction
CONCLUSIONS: Alteplase intravenous thrombolysis combined with butylphthalide in the treatment of severe cerebral infarction is safe, and may significantly improve patient's neurological function and quality of life without adverse reactions.PMID:36734384 | DOI:10.5114/fn.2022.118787
Source: Folia Neuropathologica - February 3, 2023 Category: Pathology Authors: Zhengqian Wang Junshuang Che Source Type: research
